Team – Multiply Labs

Science & Engineering Stories

Slide

Alice Melocchi

Co-Founder & CSO

Thinking out of the box, even discussing the application potential of crazy ideas, has always represented Alice's distinguishing feature. She had the original intuition of using robotics for manufacturing personalized drug dosage forms, bringing a radical innovation in pharmaceutical manufacturing: That's the core of Multiply Lab's technology. Her research has received several scientific awards, including the Best Paper Award in the Journal of Drug Delivery Science and Technology. Alice runs MultiplyLabs's pharmaceutical research effort, co-authoring all of Multiply Lab's IP and scientific publications. Would you like to join Alice? If you would like to challenge yourself in a poorly explored field at the intersection between pharma and robotics and be one of its forerunners, you should!

Slide

Jeff Curhan, P.E.

VP of Robotics Product Engineering

Creativity plays a key role in my approach to engineering. I hold a BS/MS in Mechanical Engineering, have 30 US patents, and extensive hands-on experience in robotics, machining – fabrication, and development of automated machinery. I have worked on manufacturing automation of various industries including medical devices, electronics, consumer, and automotive…. And have also been involved in competitive Battlebots. Our engineering team is revolutionizing drug therapy manufacturing with robots. It is really an incredible combination of fun and challenging work in kind of an engineering playground environment where things happen fast, and key responsibilities are given to everyone. If you are relentlessly passionate about robotics and dream of joining a rock star team, then Multiply Labs is the place to be.

Slide

Umberto Scarfogliero

VP of Robotics R&D

At MultiplyLabs, we work on an unprecedented challenge: making personalized drugs available at scale. And we do that by developing, often from scratch, robotics systems that can produce cell therapies and capsules like a human scientist would, but at an unprecedented scale and quality. This enables these complex and expensive therapies to be more easily available. After bringing on the market several different kinds of robots, from surgical to consumer robots, being here to make drugs safer, cheaper, and more broadly available is incredibly rewarding and motivating.

I am super proud of our R&D team and look forward to seeing what the new hires can bring in.